Medical Oncology

, Volume 29, Issue 3, pp 1581–1585 | Cite as

GGCn polymorphism of eRF3a/GSPT1 gene and breast cancer susceptibility

  • Mahboobe Miri
  • Simin Hemati
  • Foruzan Safari
  • Manoochehr TavassoliEmail author
Original Paper


The significance of translation regulatory factors in elevating the risk of cancer has been recently recognized. Eukaryotic release factor 3a (eRF3a) is a translation termination protein that is encoded by G1 to S phase transition 1 gene (GSPT1). The eRF3a/GSPT1 exon 1 contains a trinucleotide GGC repeat coding for a polyglycine expansion in the N-terminal of the protein. In the present study, we determined the allelic length of the GGCn repeat in the eRF3a gene in 250 women with breast cancer and 250 age-matched controls. Our results show that the presence of the longer allele, 12-GGC, is correlated with threefold increased risk of breast cancer development. Our findings also suggest that women who are homozygous for 7-GGC allele are possibly at higher risk of developing breast cancer, especially before the age of 50. No significant effect of the allelic length of eRF3a/GSPT1 polymorphism on inheritance or the grade of this disease was observed.


eRF3a/GSPT1 GGC repeat Microsatellite Breast cancer 



The authors wish to thank all patients who contributed to this investigation and Professor Farzin Farzaneh (Kings College London) for valuable suggestions and critical reading of this manuscript. This work was supported by University of Isfahan.

Conflicts of interest

The authors report no conflict of interest.


  1. 1.
    Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res. 2004;6:229–39.PubMedCrossRefGoogle Scholar
  2. 2.
    Johnson N, Dickson-Swift V. It usually happens in older women: young women’s perceptions about breast cancer. Health Educ J. 2008;67(4):243–57.CrossRefGoogle Scholar
  3. 3.
    Harirchi I, Ebrahimi M, Zamani N, Jarvandi S, Montazeri A. Breast cancer in Iran: a review of 903 case records. Public Health. 2000;114:143–5.PubMedGoogle Scholar
  4. 4.
    Mousavi SM, Montazeri MA, Mousavi Jarrahi A, Harirchi I, Najafi M, Ebrahimi M. Breast cancer in Iran: an epidemiological review. Breast J. 2007;13:383–91.PubMedCrossRefGoogle Scholar
  5. 5.
    Zhouravleva G, Frolova L, Le Goff X, et al. Termination of translation in eukaryotes in governed by two interacting polypeptide chain release factors, eRF1and eRF3. EMBO J. 1995;14:4065–72.PubMedGoogle Scholar
  6. 6.
    Hoshino S, Hosoda N, Araki T, et al. Novel function of the eukaryotic polypeptide-chain releasing factor 3 (eRF3/GSPT) in the mRNA degradation pathway. Biochemistry. 1999;64(12):1367–72.PubMedGoogle Scholar
  7. 7.
    Hoshino S, Ima M, Mizutani M, et al. Molecular cloning of the eukaryotic polypeptide releasing factors (eRF): its identification as eRF3 interacting with eRF1. J Biol Chem. 1998;273:22254–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Chauvin C, Salhi S, Jean–Jean O. Human eukaryotic release factor 3a depletion causes cell cycle arrest at G1 phase through inhibition of the mTOR pathway. Mol Cell Biol. 2007;27:5619–29.PubMedCrossRefGoogle Scholar
  9. 9.
    Valouev IA, Kushnirov VV, Tre-Avanesyan MD. Yeast polypeptide chain release factors eRF1and eRF3 are involved in cytoskeleton organization and cell cycle regulation. Cell Motil Cytoskeleton. 2002;52:161–73.PubMedCrossRefGoogle Scholar
  10. 10.
    Lee JA, Park JE, Lee DH, et al. G1 to S phase transition protein 1 induces apoptosis signal-regulating kinase1 activation by dissociating 14–3-3 from ASK1. Oncogene. 2008;27:1297–305.PubMedCrossRefGoogle Scholar
  11. 11.
    Hedge R, Srinivasula SM, Datta P, et al. The polypeptide chain-releasing factor GSPT1/eRF3 is proteolytically processed into an IAP-binding protein. J Biol Chem. 2003;278:38699–706.CrossRefGoogle Scholar
  12. 12.
    Ozawa K, Murakami Y, Eki T, Yokoyama K, et al. Mapping of the human GSPT1 gene, a human homolog of the yeast GST1 gene, to chromosomal band 16p13.1. Somat Cell Mol Genet. 1992;18:189–94.PubMedCrossRefGoogle Scholar
  13. 13.
    Hansen LL, Jakobsen CG, Justesen J. Assignment of the human peptide chain release factor 3 (GSPT2) to Xp11.23Rp11.21 and of the distal marker DXS1039 by radiation hybrid mapping. Cytogenet Cell Genet. 1999;86:250–1.PubMedCrossRefGoogle Scholar
  14. 14.
    Chauvin C, Salhi S, Le Goff W, et al. Involvement of human release factors eRF3a and eRF3b in translation termination and regulation of the termination complex formation. Mol Cell Biol. 2005;25:5801–11.PubMedCrossRefGoogle Scholar
  15. 15.
    Brito M, Malta-Vacas J, Carmona B, et al. Polyglycine expansions in eRF3/GSPT1 are associated with gastric cancer susceptibility. Carcinogenesis. 2005;26:2046–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Malta-Vacas J, Chauvin C, Gonçalves L, et al. eRF3a/GSPT1 12-GGC allele increases the susceptibility for breast cancer development. Oncol Rep. 2009;21:1551–8.PubMedGoogle Scholar
  17. 17.
    Malta-Vacas J, Ferreira P, Monterio C, Brito M. Differential expression of GSPT1 GGC n alleles in cancer. Cancer Genet Cytogenet. 2009;195:132–42.PubMedCrossRefGoogle Scholar
  18. 18.
    Tallheden T, Karlsson C, Brunner A. Gene expression during redifferentiation of human articular chondrocytes. Osteoarthr Cartil. 2004;12:225–35.CrossRefGoogle Scholar
  19. 19.
    Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.PubMedCrossRefGoogle Scholar
  20. 20.
    Basu J, Williams BC, Li Z, Williams EV, Goldberg ML. Depletion of a Drosophila homolog of yeast Sup35p disrupts spindle assembly, chromosome segregation, and cytokinesis during male meiosis. Cell Motil Cytoskeleton. 1998;39:286–302.PubMedCrossRefGoogle Scholar
  21. 21.
    Eastmond DA, Tucker JD. Identification of aneuploidy-inducing agents using cytokinesis-blocked human lymphocytes, and an antikinetochore antibody. Environ Mol Mutagen. 1989;13:34–43.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Mahboobe Miri
    • 1
  • Simin Hemati
    • 2
  • Foruzan Safari
    • 1
  • Manoochehr Tavassoli
    • 1
    Email author
  1. 1.Department of Biology, Faculty of SciencesUniversity of IsfahanIsfahanIran
  2. 2.Radiation Oncology DepartmentIsfahan University of Medical SciencesIsfahanIran

Personalised recommendations